Literature DB >> 7992967

Liver metastases from colorectal carcinoma: incidence, resectability, and survival results.

K E Zavadsky1, Y T Lee.   

Abstract

We studied 328 cases of colorectal carcinoma (stages I-IV) seen at our hospital during a 19-year period. We found that 15% of these had liver metastasis (LM) at initial diagnosis, and 14% developed LM after resection of their primary cancers. Among the 73 patients with LM, the lesion was confined to the liver (LM only) in 40 patients. Using our criteria of "resectability" of LM, 45% with LM only had resectable LM lesions, but only 15% (six patients) actually had hepatic resections. We had no operative death nor major complication. Five of the six patients with LM resected lived 3 years or longer, but none of the other 34 patients with LM only (either non-resectable or resectable but not operated on) lived more than 35 months. Although our series is relatively small, our data are consistent with results coming from other national and institutional studies. The controversies and issues relating to resection of colorectal liver metastasis are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7992967

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  13 in total

1.  Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group.

Authors:  Wing M Ho; B Ma; Tony Mok; W Yeo; Paul Lai; R Lim; Jane Koh; Y Y Wong; Ann King; C K Leow; A T C Chan
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 2.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

3.  Concepts and preliminary data toward the realization of image-guided liver surgery.

Authors:  David M Cash; Michael I Miga; Sean C Glasgow; Benoit M Dawant; Logan W Clements; Zhujiang Cao; Robert L Galloway; William C Chapman
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

4.  Hepatic cryosurgery for liver metastases. Long-term follow-up.

Authors:  N N Korpan
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

5.  Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?

Authors:  Seung Soo Kim; Kyoung Doo Song; Young Kon Kim; Hee Cheol Kim; Jung Wook Huh; Young Suk Park; Joon Oh Park; Seung Tae Kim
Journal:  Eur Radiol       Date:  2016-11-04       Impact factor: 5.315

Review 6.  Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Authors:  G Scott Gazelle; M G Myriam Hunink; Karen M Kuntz; Pamela M McMahon; Elkan F Halpern; Molly Beinfeld; Jessica S Lester; Kenneth K Tanabe; Milton C Weinstein
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

7.  Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver.

Authors:  Junaid Ibrahim; Andrew H Nguyen; Adeel Rehman; Atsuo Ochi; Mohsin Jamal; Christopher S Graffeo; Justin R Henning; Constantinos P Zambirinis; Nina C Fallon; Rocky Barilla; Sana Badar; Aaron Mitchell; Raghavendra S Rao; Devrim Acehan; Alan B Frey; George Miller
Journal:  Gastroenterology       Date:  2012-06-12       Impact factor: 22.682

8.  Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases.

Authors:  M F Gnant; M Puhlmann; D L Bartlett; H R Alexander
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

9.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

10.  Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.

Authors:  Wei-Zhong Cheng; Meng-Su Zeng; Fu-Hua Yan; Shen-Xiang Rao; Ji-Zhang Shen; Cai-Zhong Chen; Shu-Jie Zhang; Wei-Bin Shi
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.